NCT07215611Recruiting
Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas
Source: ClinicalTrials.gov · Last updated 11 Sept 2026
Brief summary (registry, in English)
To learn about the financial stress patients undergoing surgery to treat orthopedic cancer experience because of the costs of cancer care, and to learn about the effects of financial stress on participants quality of life.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 9 Oct 2025
- Start date
- 2 Sept 2025
- Primary completion date
- 2 Oct 2028
- Lead sponsor
- M.D. Anderson Cancer Center
- Diseases
- Childhood cancers, Sarcoma
- NCT number
- NCT07215611
What you commit to
- Study type: Observational
- Planned participants: 100
- From 2 Sept 2025 to the primary completion date, 2 Oct 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Non-English subjects will not be recruited. Subjects are required to be able to read/write in English.
Who the study is looking for
- Participants who are seen preoperatively at our institution before surgery for primary malignant bone tumor or primary malignant soft tissue tumor will be identified.
- Adult orthopedic oncology patients. Stratified by diagnosis of primary malignant bone tumor and primary malignant soft tissue tumor.
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| MD Anderson Cancer Center Coordinator of this site? Confirm its status | Houston | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.